The United States Food and Drug Administration (FDA) has authorized the use of the Pfizer-BioNTech Covid-19 vaccine for children ages 12-15 in the United States.
This move will allow for more people in the country to be vaccinated and a faster return to normalcy.
To date, over 260 million doses of the vaccine have been administered in the U.S., but demand has been falling.
The decision follows a clinical trial by Pfizer and BioNTech involving 2,260 children aged 12 to 15.
The FDA’s seal of approval is not the final regulatory hurdle. An advisory panel of the Centers for Disease Control and Prevention (CDC) will review the data soon.
Readers Bureau, Contributor
Edited by Jesus Chan
Do you want to add feedback to this story?
Please add a comment in the box below or send an email to firstname.lastname@example.org, send us a message on WhatsApp at 646-874-7976 or Call us at 201-500-7715